Birmingham, AL2 Active Studies

Peripheral Artery Disease Clinical Trials in Birmingham, AL

Find 2 actively recruiting peripheral artery disease clinical trials in Birmingham, AL. Connect with local research sites and explore new treatment options.

2
Active Trials
2
Sponsors
1,430
Enrolling

Recruiting Peripheral Artery Disease Studies in Birmingham

About Peripheral Artery Disease Clinical Trials in Birmingham

Peripheral artery disease (PAD) is a circulatory condition where narrowed arteries reduce blood flow to the limbs, especially the legs. Common symptoms include leg pain when walking (claudication). Treatment includes lifestyle changes, medications, and sometimes procedures to improve blood flow.

There are currently 2 peripheral artery disease clinical trials recruiting participants in Birmingham, AL. These studies are seeking a combined 1,430 participants. Research is being sponsored by Eli Lilly and Company, VA Office of Research and Development. Clinical trial participation is free and participants receive study-related medical care at no cost.

Peripheral Artery Disease Clinical Trials in Birmingham — FAQ

Are there peripheral artery disease clinical trials in Birmingham?

Yes, there are 2 peripheral artery disease clinical trials currently recruiting in Birmingham, AL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Birmingham?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Birmingham research site will contact you about next steps.

Are clinical trials in Birmingham free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Birmingham studies also compensate for your time and travel.

What peripheral artery disease treatments are being tested?

The 2 active trials in Birmingham are testing new therapies including novel drugs, biologics, and treatment approaches for peripheral artery disease.

Data updated July 18, 2026 from ClinicalTrials.gov